SVN-015

N/A

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameSVN-015
Drug Alias NameSVN-015SVN015
ClassificationSmall molecules
Mechanisms of ActionDopamine reuptake inhibitors
TargetsDopamine transporter
Therapy Area/IndicationsDepressive Disorder, MajorCocaine-Related DisordersSubstance-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSolvonis Therapeutics plc
China Registration ClassN/A

Develop Information

Active CompaniesSolvonis Therapeutics plc
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorCocaine-Related DisordersSubstance-Related Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A